FDA.reportPublic FDA data

levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet

RxCUI
1605372
RxNorm name
levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet
Display name
levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet
Full name
levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ELEPSIA XR 1000 MGLEVETIRACETAMTRIPOINT THERAPEUTICS, LLCcac83d47-88a2-4447-a0c0-90b44ffda0ac2024-03-25Warnings, Adverse reactionsExact identifier
rxcui: 1605372

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cac83d47-88a2-4447-a0c0-90b44ffda0aclevETIRAcetam 1500 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR levetiracetam 1500 MG Extended Release Oral Tablet [SCD] · levetiracetam 1500 MG 24 HR Extended Release Oral Tablet [SY]35These highlights do not include all the information needed to use ELEPSIA XR safely and effectively. See full prescribing information for ELEPSIA XR. ELEPSIA™ XR (levetiracetam) extended-release tablets, for oral use Initial U.S. Approval: 199920240325